Summary & Overview
HCPCS J7301: Levonorgestrel-releasing Intrauterine Contraceptive System (Skyla)
HCPCS Level II code J7301 identifies the levonorgestrel-releasing intrauterine contraceptive system (Skyla), 13.5 mg. The code is used for billing the device/drug product associated with long-acting reversible contraception (LARC) when the device is supplied for insertion. Nationally, accurate coding for LARC products like Skyla is important for access to contraceptive care, claims processing, and cost tracking across outpatient and ambulatory settings.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, commonly associated payer coverage considerations, and practical benchmarks for service-line classification. The publication outlines reimbursement and billing themes relevant to device-supply codes, summarizes payment variability among major national payers, and highlights policy or coding updates that affect billing for intrauterine contraceptive systems.
The piece is designed to help billing managers, practice administrators, and policy analysts understand where J7301 fits in clinical workflows, how it is reported on claims, and what items to review when reconciling payments for IUD supply and insertion services.
Billing Code Overview
HCPCS Level II code J7301 denotes the levonorgestrel-releasing intrauterine contraceptive system (Skyla), 13.5 mg. This code represents the drug/device product used for long-acting reversible contraception delivered via an intrauterine system.
Service type: Contraceptive intrauterine device placement (drug-device product)
Typical site of service: Outpatient clinic, ambulatory surgery center, or office-based gynecology setting
Clinical & Coding Specifications
Clinical Context
A 28-year-old woman presents to a family planning clinic requesting long-acting reversible contraception. She has completed counseling on options and selects the levonorgestrel-releasing intrauterine contraceptive system (brand: Skyla, J7301). The visit includes informed consent, pregnancy testing as indicated, a brief history and focused pelvic exam, and point-of-care procedures for insertion. The typical clinical workflow: pre-procedure counseling and consent; confirm no pregnancy (urine hCG if indicated); pelvic exam and cervical cleaning; uterine sounding and insertion of the J7301 device under aseptic technique; immediate post-insertion check of strings and brief observation for vasovagal symptoms; documentation of lot number and device expiration; patient education on expected bleeding changes and follow-up plan. Typical sites of service are outpatient clinic, family planning clinic, or ambulatory surgery center when performed with additional procedures or anesthesia. Typical patient scenario includes nulliparous or parous reproductive-aged women seeking 3-year levonorgestrel IUD for contraception or management of heavy menstrual bleeding when appropriate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |